Article Details
Retrieved on: 2025-02-13 13:21:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies ... monoclonal antibodies, such as long ...
Article found on: via.ritzau.dk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here